BBLG

0.26852.40%
SR

Siddhesh Rajendra Angle

Independent Director

Dr. Siddhesh Rajendra Angle, Ph.D., also known as Sid, is Founder, President & Chief Executive Officer of Regenosine, Inc. He has been an Independent Director of Bone Biologics Corporation since October 2021. He has been is Co-Founder, President and Chief Executive Officer of Regenosine since 2017. From 2021 to present, Dr. Angle also serves on the Executive Team of Vetosine, an animal health affiliate of Regenosine. From 2020 to 2021, Dr. Angle was Associate Director, Innovation Commercialization at NYU Langone. From 2017 to 2020, Dr. Angle was Program Manager, Innovation Commercialization at NYU Langone. From 2013 to 2017, Dr. Angle worked in various R&D capacities at Zimmer Biomet, culminating as R&D Manager of global orthobiologics. From 2011 to 2013, Dr. Angle served as Research Scientist at Carnegie Mellon University. Dr. Angle has musculoskeletal research and development experience. Previously he was the R&D Manager for Zimmer Global Biologics. Dr. Angle has worked at several startups and successfully commercialized orthopedic medical devices and combination therapies. He holds an MS and Ph.D. from University of Illinois at Chicago.

Positions